Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor. (Record no. 30493088)

MARC details
000 -LEADER
fixed length control field 01331 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518080343.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202103s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1090-2120
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.bioorg.2019.103547
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wang, Cheng
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210308
245 00 - TITLE STATEMENT
Title Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Bioorganic chemistry
Date of publication, distribution, etc. 01 2020
300 ## - PHYSICAL DESCRIPTION
Extent 103547 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Design
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Syk Kinase
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Xin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, Yao
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wang, Tianqi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Zhi
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Qin, Zhongxiang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yang, Shengyong
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xiang, Rong
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fan, Yan
773 0# - HOST ITEM ENTRY
Title Bioorganic chemistry
Related parts vol. 95
-- p. 103547
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.bioorg.2019.103547">https://doi.org/10.1016/j.bioorg.2019.103547</a>
Public note Available from publisher's website

No items available.